NYSEFinancialsInsurance - DiversifiedSnapshot 2026-08-31
Reading XZO? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Recent financial performance freshly dropped to the bottom half of its industry.
View ThesisManagement screens strong on capital allocation, earnings delivery.
View ManagementExpectations look high — the market is pricing in about 54% growth a year, above the roughly 13% analysts expect, leaving little room for error.
View ValuationThis stock is highly volatile — it swings about 2% on a typical day and fell roughly 48% in its worst 12-month stretch.
View RiskXZO's growth depends on advancing AI initiatives and product innovation to justify its price. Revenue grew 8% year over year, and the last quarter beat expectations. It trades at 5.2× price-to-book versus a peer median of 1.3×. The market is pricing in more growth than we forecast, indicating expectations look full. The recent financial performance dropped to the bottom half of its industry, which weakens the case for ownership. Peer multiples imply a price about 55% below where it trades (it looks expensive on this basis). This read is provisional.
Trailing returns as of 2026-08-31. XZO is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 3 analysts currently covering XZO (as of Aug 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-08-31. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Multi-line Insurance — fair value, gap to price, and forward P/E.
Advances: Advance product innovation and platform expansion
AI initiatives enhance product innovation and platform expansion.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-08-31. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Share repurchase program authorization
Share buyback supports capital allocation and shareholder value.
Advances: Share buyback program of $12 million
Buyback program supports capital allocation objective.
Advances: Share buyback program of $12 million
Authorization of buyback aligns with capital allocation strategy.
